Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes

Critical Reviews in Toxicology

Volumn 37, Issue 5, 2007, Pages 413-459

  Wang, T ^a   Shankar, K ^b   Ronis, M J ^b   Mehendale, H M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Diabetes; Drug Metabolism; Hepatotoxicity; Liver Tissue Repair

Indexed keywords

1,1,2 TRICHLOROETHANE; ALLYL ALCOHOL; ANTIDIABETIC AGENT; BROMOBENZENE; CARBON TETRACHLORIDE; CHLOROFORM; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2A; CYTOCHROME P450 2A1; CYTOCHROME P450 2B1; CYTOCHROME P450 2C; CYTOCHROME P450 2C11; CYTOCHROME P450 2C12; CYTOCHROME P450 2E1; CYTOCHROME P450 3A1; CYTOCHROME P450 3A2; CYTOCHROME P450 4A1; DRUG METABOLIZING ENZYME; GALACTOSAMINE; MENADIONE; NITROSAMINE; PARACETAMOL; PIOGLITAZONE; ROSIGLITAZONE; SULFOTRANSFERASE; THIOACETAMIDE; TROGLITAZONE; UNINDEXED DRUG;

DETOXIFICATION; DISEASE COURSE; DRUG MECHANISM; DRUG WITHDRAWAL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FUNCTION; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; SENSITIVITY ANALYSIS; STREPTOZOCIN DIABETES; TISSUE REPAIR; ZUCKER DIABETIC FATTY RAT;

ANIMALS; DIABETES MELLITUS; DRUG INTERACTIONS; HEPATITIS, TOXIC; HUMANS; LIVER DISEASES; LIVER REGENERATION; MICE; RATS; SPECIES SPECIFICITY; SURVIVAL RATE; TOXINS, BIOLOGICAL; XENOBIOTICS;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 34447128300     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440701215100     Document Type: Review

References (440)

1. Abdelmegeed, M.A., Carruthers, N.J., Woodcroft, K.J., Kim, S.K., and Novak, R.F. (2005). Acetoacetate induces CYP2E1 protein and suppresses CYP2E1 mRNA in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 315:203.
2. Abbott, C.A., Mackness, M.I., Kumar, S., Olukoga, A.O., Gordon, C., Arrol, S., Bhatnagar, D., Boulton, A.J., and Durrington, P.N. (1993). Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clin. Sci. (Lond.) 85:77.
3. Ackerman, D.M., and Leibman, K.C. (1977). Effect of experimental diabetes on drug metabolism in the rat. Drug Metab. Dispos. 5:405.
4. Akkus, I., Kalak, S., Vural, H., Caglayan, O., Menekse, E., Can, G., and Durmus, B. (1996). Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin. Chim. Acta 244:221.
5. Albrecht, J.H., and Hansen, L.K. (1999). Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ. 10:397.
6. Alexander, D.P., Britton, H.G., Cohen, N.M., Mashiter, K., Nixon, D.A., and Smith, F.G., Jr (1971). Streptozotocin induced diabetes in the newborn lamb. Biol. Neonate 17:381.
7. Al-Salman, J., Arjomand, H., Kemp, D.G., and Mittal, M. (2000). Hepatocellular injury in a patient receiving rosiglitazone. A case report. Ann. Intern. Med. 132:121.
8. Altomare, E., Grattagliano, I., Vendemaile, G., Micelli-Ferrari, T., Signorile, A., and Cardia, L. (1997). Oxidative protein damage in human diabetic eye: Evidence of a retinal participation. Eur. J. Clin. Invest. 27:141.
9. Al-Turk, W.A., Stohs, S.J., and Roche, E.B. (1981). Altered activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and adrenalectomized diabetic rats. Pharmacology 23:337.
10. am Esch, J.S. 2nd, Knoefel, W.T., Klein, M., Ghodsizad, A., Fuerst, G., Poll, L.W., Piechaczek, C., Burchardt, E.R., Feifel, N., Stoldt, V., Stockschlader, M., Stoecklein, N., Tustas, R.Y., Eisenberger, C.F., Peiper, M., Haussinger, D., and Hosch, S.B. (2005). Portal application of autologous CD133+ bone marrow cells to the liver: A novel concept to support hepatic regeneration. Stem Cells 23:463.
11. Anai, M., Funaki, M., Ogihara, T., Terasaki, J., Inukai, K., Katagiri, H., Fukushima, Y., Yazaki, Y., Kikuchi, M., Oka, Y., and Asano, T. (1998). Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47:13.
12. Anderson, H.R., Stitt, A.W., Gardiner, T.A., Lloyd, S.J., and Archer, D.B. (1993). Induction of alloxan/streptozotocin diabetes in dogs: A revised experimental technique. Lab. Anim. 27:281.
13. Anderson, S.P., Yoon, L., Richard, E.B., Dunn, C.S., Cattley, R.C., and Corton, J.C. (2002). Delayed liver regeneration in peroxisome proliferator-activated receptor-alpha-null mice. Hepatology 36:544.
14. Andrade, R.J., Lucena, M.I., and Rodriguez-Mendizabal, M. (1996). Hepatic injury caused by acarbose. Ann. Intern. Med. 124:931.
15. Andrade, R.J., Lucena, M., Vega, J.L., Torres, M., Salmeron, F.J., Bellot, V., Garcia-Escano, M.D., and Moreno, P. (1998). Acarbose-associated hepatotoxicity. Diabetes Care 21:2029.
16. Aniya, Y., Ojiri, Y., Sunagawa, R., Murakami, K., Zhenzhong, G., Mimura, G., and Sakanashi, M. (1989). Glutathione S-transferases and chloroform toxicity in streptozotocin-induced diabetic rats. Jpn. J. Pharmacol. 50:263.
17. Annapurna, V., Senciall, I., Davis, A.J., and Kutty, K.M. (1991). Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats. Diabetologia 34:320.
18. Apte, U.M., Limaye, P.B., Ramaiah, S.K., Desaiah, D., Bucci, T.J., Warbritton, A., and Mehendale, H.M. (2003). Mechanisms of higher liver tissue repair and survival in diet restricted rats treated with thioacetamide. Toxicol. Sci. 72:272.
19. Aragno, M., Tamagno, E., Gatto,V., Brignardello, E., Parola, S., Danni, O., and Boccuzzi, G. (1999). Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. Free Radical Biol. Med. 26:1467.
20. Argiles, J.M. (1989). The obese Zucker rat: a choice for fat metabolism 1968-1988: Twenty years of research on the insights of the Zucker mutation. Prog. Lipid Res. 28:53.
21. Asayama, K., Sandhir, R., Sheikh, F.G., Hayashibe, H., Nakane, T., and Singh, I. (1999). Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferatoractivated receptor-alpha in diabetic rat liver. Mol. Cell Biochem. 194:227.
22. Atalay, M., Laaksonen, D.E., Niskanen, L., Uusitupa, M., Hanninen, O., and Sen, C.K. (1997). Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol. Scand. 161:195.
23. Aughsteen, A.A. (2000). An ultrastructural study on the effect of streptozotocin on the islets of Langerhans in mice. J. Electron Microsc. (Tokyo) 49:681.
24. Awad, M.M., Enslen, H., Boylan, J.M., Davis, R.J., and Gruppuso, P.A. (2000). Growth regulation via p38 mitogen-activated protein kinase in developing liver. J. Biol. Chem. 275:38716.
25. Aznar Aznar, A., Sanchez Canizares, T., Bentura Remacha, M.L., Lopez Alonso, A., and Diaz Pavon, L. (1991). Effect of alloxan-induced diabetes on hepatic regeneration. Rev. Esp. Enferm. Dig. 79:313 (abstract).
26. 2 hepatoma cells. Mol. Pharmacol. 63:401.
27. Bahjat, F.R., Dharnidharka, V.R., Fukuzuka, K., Morel, L., Crawford, J.M., Clare-Salzler, M.J., and Moldawer, L.L. (2000). Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality. J. Immunol. 165:6559.
28. Bandyopadhyay, A.M., Chaudhary, I., Robertson, L.W., Gemzik, B., Parkinson, A., and Blouin, R.A. (1993). Expression of a male-specific cytochrome P450 isozyme (CYP2C11) in fa/fa Zucker rats: Effect of phenobarbital treatment. Arch. Biochem. Biophys. 307:386.
29. Barnett, C.R., Abbott, R.A., Bailey, C.J., Flatt P.R., and Ioannides, C. (1992). Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. Biochem. Pharmacol. 43:1868.
30. Barnett, C.R., Flatt, P.R., and Ioannides, C. (1994). Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes. J. Biochem. Toxicol. 9:63.
31. Barnett, C.R., Flatt, P.R., and Ioannides, C. (1990a). Induction of hepatic microsomal P450 I and IIB proteins by hyperketonaemia. Biochem. Pharmacol. 40:393.
32. Barnett, C.R., Gibson, G.G., Wolf, C.R., Flatt, P.R., and Ioannides, C. (1990b). Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes. Biochem. J. 268:765.
33. Barnett, C.R., Rudd, S., Flatt, P.R., and Ioannides, C. (1993). Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteins. Biochem. Pharmacol. 45:313.
34. Barra, R., and Hall, J.C. (1977). Liver regeneration in normal and alloxan-induced diabetic rats. J. Exp. Zool. 201:93.
35. Bastar, I., Seckin, S., Uysal, M., and Aykac-Toker, G. (1998). Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res. Commun. Mol. Pathol. Pharmacol. 102:265.
36. Baynes, J.W. (1991). Role of oxidative stress in development of complications in diabetes. Diabetes. 40:405.
37. Baynes, J.W., and Thorpe, S.R. (1999). Role of oxidative stress in diabetic complications:Anewperspective on an old paradigm. Diabetes 48:1.
38. Bellward, G.D., Chang, T., Rodrigues, B., McNeill, J.H., Maines, S., Ryan, D.E., Levin,W., and Thomas, P.E. (1988). Hepatic cytochrome P-450 induction in the spontaneously diabetic BB rat. Mol. Pharmacol. 33:140.
39. Blouin, R.A., Bandyopadhyay, A.M., Chaudhary, I., Robertson, L.W., Gemzik, B., and Parkinson, A. (1993). Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: Molecular characterization. Arch. Biochem. Biophys. 303:313.
40. Boelsterli, U.A. (2003). Disease-related determinants of susceptibility to drug-induced idiosyncratic hepatotoxicity. Curr. Opin. Drug Discov. Devel. 6:81.
41. Bonkovsky, H.L., Azar, R., Bird, S., Szabo, G., and Banner, B. (2002). Severe cholestatic hepatitis caused by thiazolidinediones: Risks associated with substituting rosiglitazone for troglitazone. Dig. Dis. Sci. 47:1632.
42. Booth, A.M., Caldwell, S.H., and Iezzoni, J.C. (2000). Troglitazone-associated hepatic failure. Am. J. Gastroenterol. 95:557.
43. Borthwick, E.B., Burchell, A., and Coughtrie, M.W. (1995). Differential expression of hepatic oestrogen, phenol and dehydroepiandrosterone sulphotransferases in genetically obese diabetic (ob/ob) male and female mice. J. Endocrinol. 144:31.
44. Braun, L., Coffey, M.J., Puskas, F., Kardon, T., Nagy, G., Conley, A.A., Burchell, B., and Mandl, J. (1998). Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats. Biochem. J. 336:587.
45. Brenner, D.A. (1998). Signal transduction during liver regeneration. J. Gastroenterol. Hepatol. 13:S93.
46. Brownlee, M. (1993). Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 43:836.
47. Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46:223.
48. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414:813.
49. Bruccoleri, A., Gallucci, R., Germolec, D.R., Blackshear, P., Simeonova, P., Thurman, R.G., and Luster, M.I. (1997). Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25:133.
50. Carmiel-Haggai, M., Cederbaum, A.I., and Nieto, N. (2003). Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 125:1818.
51. Carnovale, C.E., Catania, V.A., Monti, J.A., and Carrillo, M.C. (1992). Differential effects of blood insulin levels on microsomal enzyme activities from hepatic and extrahepatic tissues of male rats. Can. J. Physiol. Pharmacol. 70:727.
52. Carrascosa, M., Pascual, F., and Aresti, S. (1997). Acarbose-induced acute severe hepatotoxicity. Lancet 349:698.
53. Caruana, J.A., Whalen, D.A. Jr, Anthony, W.P., Sunby, C.R., and Ciechoski, M.P. (1986). Paradoxical effects of glucose feeding on liver regeneration and survival after partial hepatectomy. Endocr. Res.12:147.
54. Catala, J., Hadjiisky, P., Bonnafous, R., and Fichaux, F. (1990). Cell features in pancreas of prediabetic and diabetic rabbits afterWirsung duct ligation. Histochemical and histoenzymatic studies. Acta Diabetol. Lat. 27:59.
55. Catala, J., Daumas, M., Chanh, A.P., Lasserre, B., and Hollande, E. (2001). Insulin and glucagon impairments in relation with islet cells morphological modifications following long term pancreatic duct ligation in the rabbit - A model of noninsulin-dependent diabetes. Int. J. Exp. Diabetes Res. 2:101.
56. Cataldegirmen, G., Zeng, S., Feirt, N., Ippagunta, N., Dun, H., Qu, W., Lu, Y., Rong, L.L., Hofmann, M.A., Kislinger, T., Pachydaki, S.I., Jenkins, D.G., Weinberg, A., Lefkowitch, J., Rogiers, X., Yan, S.F., Schmidt, A.M., and Emond, J.C. (2005). RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J. Exp. Med. 201:473.
57. Cerami, A., Vlassara, H., and Brownlee, M. (1988). Role of advanced glycosylation products in complications of diabetes. Diabetes Care 11(Suppl. 1):73.
58. Cervinkova, Z., Kalinova, M., and Simek, J. (1992). The effect of carnitine on the early phase of liver regeneration after partial hepatectomy in rats with experimental diabetes. Bratisl. Lek. Listy. 93:359 (abstract).
59. Chance, B., Sies, H., andBoveris A. (1979). Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:527.
60. Chanda, S., and Mehendale, H.M. (1995). Nutritional impact on the final outcome of liver injury inflicted by model hepatotoxins: effect of glucose loading. FASEB J. 9:240.
61. Chen, G.F., Ronis, M.J., Ingelman-Sundberg, M., and Badger, T.M. (1999). Hormonal regulation of microsomal cytochrome P4502E1 and P450 reductase in rat liver and kidney. Xenobiotica 29:437-451.
62. Chen, X., Zheng, Y., and Shen, Y. (2006). Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors. Curr. Med. Chem. 13:109.
63. Chilakapati, J., Korrapati, M.C., Hill, R.A., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. (2007a). Role of thioacetamide sfoxide in saturation of Toxicokinetics of thioacetamide. Toxicology. in press.
64. Chilakapati, J., Korrapati, M.C., Shankar, K., Hill, R.A., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. (2007b). Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital. Toxicol. Appl. Pharmacol. in press.
65. Chin, S., Ramirez, S., Greenbaum, L.E., Naji, A., and Taub, R. (1995). Blunting of the immediate-early gene and mitogenic response in hepatectomized type 1 diabetic animals. Am. J. Physiol. 269:E691.
66. Cillo, U., Vitale, A., Brolese, A., Zanus, G., Bassanello, M., Montin, U., D'Amico, F., Ciarleglio, F.A., Iurilli, V., Carraro, P., Grigoletto, F., Plebani, M., and D'Amico, D.F. (2005). Syngeneic living-donor liver transplantation for hemangioendothelioma: A clinical model for studying liver regeneration. Am. J. Transplant 5:2309.
67. Clarke, J., Snelling, J., Ioannides, C., Flatt, P.R., and Barnett, C.R. (1996). Effect of vitamin C supplementation on hepatic cytochrome P450 mixed-function oxidase activity in streptozotocin-diabetic rats. Toxicol. Lett. 89:249.
68. Conaway, H.H., Brown, C.J., Sanders, L.L., Cernosek, S.F., Farris, H.E., and Roth, S.I. (1980). Spontaneous diabetes mellitus in the New Zealand white rabbit: History, classification, and genetic analysis. J. Hered. 71:179-186.
69. Cornwell, P.D., and Watkins, J.B. (2001). Changes in the kinetic parameters of hepatic gamma-glutamyltransferase from streptozotocin-induced diabetic rats. Biochem. Biophys. Acta 1545:184.
70. Coughtrie, M.W., Pears, J., Jones, A.L., and Burchell, A. (1990). Cytosolic phenol and steroid sulphotransferase activities are decreased in a sex-dependent manner in streptozotocin-induced diabetic rats. Biochem. Pharmacol. 40:2180.
71. Crabb,D.W. (1986). The effect of experimental diabetes on liver alcohol dehydrogenase activity in rats. Alcohol Clin. Exp. Res. 10:77.
72. Dahlke, M.H., Popp, F.C., Bahlmann, F.H., Aselmann, H., Jager, M.D., Neipp, M., Piso, P., Klempnauer, J., and Schlitt, H.J. (2003). Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: Do bone marrow-derived cells contribute? J. Hepatol. 39:365.
73. Dajani, O.F., Refsnes, M., Guren, T.K., Horn, R.S., Thoresen, G.H., and Christoffersen, T. (1994). Elevated glucose concentrations inhibit DNA synthesis and expression of c-myc in cultured hepatocytes. Biochem. Biophys. Res. Commun. 202:1476.
74. Davis, R. (1994). MAPKs: new JNK expands the group. Trends in Biochem. Sci. 19:470.
75. De Diego, J.A., Molina, L.M., Bujan, J., Simon, P., Gea, M., Menchero, A., and Balibrea, J.L. (1986). Influence of the conjoint administration of insulin and glucagon upon hepatic regeneration. Surg. Gynecol. Obstet. 163:443.
76. De Vos, A., Heimberg, H., Quartier, E., Huypens, P., Bouwens, L., Pipeleers, D., and Schuit, F. (1995). Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J. Clin. Invest. 96:2489.
77. Del Villar, E., Vega, P., Gaule, C., and Sanchez, E. (1990). Diabetes in female rats; changes in liver microsomal aminopyrine N-demethylase and UDP-glucuronyl transferase activities. Eur. J. Drug Metab. Pharmacokinet. 15:279.
78. Devi, S.S., and Mehendale, H.M. (2005a). Disrupted G1 to S phase clearance via cyclin signaling impairs liver tissue repair in thioacetamide-treated type 1 diabetic rats. Toxicol. Appl. Pharmacol. 207:89.
79. Devi, S.S., and Mehendale, H.M. (2005b). The role of NF-kappaB signaling in impaired liver tissue repair in thioacetamide-treated type 1 diabetic rats. Eur. J. Pharmacol. 523:127.
80. Devi, S.S., and Mehendale, H.M. (2006). Microarray analysis of thioacetamide-treated type 1 diabetic rats. Toxicol. Appl. Pharmacol. 212:69.
81. Devi, S.S., Philip, B.K., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. (2006). Prior administration of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide. Toxicology 226:107.
82. Dharancy, S., Malapel, M., Perlemuter, G., Roskams, T., Podevin, P., Conti, F., Canva, V., Gambiez, L., Calmus, Y., Mathurin, P., Pol, S., Brechot, C., Auwerx, J., and Desreumaux, P. (2002). Impaired liver expression of the PPAR-α modulates liver steatosis and inflammation during hepatitis C virus infection. Hepatology 36:264A.
83. Di Campli, C., Piscaglia, A.C., Rutella, S., Bonanno, G.,Vecchio, F.M., Zocco, M.A., Monego, G., Michetti, F., Mancuso, S., Pola, P., Leone, G., Gasbarrini, G., and Gasbarrini, A. (2005). Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. Transplant Proc. 37:2707.
84. Diehl, A.M., and Rai, R.M. (1996). Liver regeneration 3: Regulation of signal transduction during liver regeneration. FASEB J. 10:215.
85. Diehl, A.M., Yin, M., Fleckenstein, J., Yang, S.Q., Lin, H.Z., Brenner, D.A., Westwick, J., Bagby, G., and Nelson, S. (1994). Tumor necrosis factor-alpha induces c-jun expression during the regenerative responses to liver injury. Am. J. Physiol. 30:G552.
86. Diehl, A.M., Yang, S.Q., Yin, M., Lin, H.Z., Nelson, S., and Bagby, G. (1995). Tumor necrosis factor-alpha modulates CCAAT/enhancer binding proteins-DNA binding activities and promotes hepatocyte-specific gene expression during liver regeneration. Hepatology 22:252.
87. Dincer, Y., Alademir, Z., Ilkova, H., and Akcay, T. (2002). Susceptibility of glutatione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control. Clin. Biochem. 35:297.
88. Donahower, B., McCullough, S.S., Kurten, R., Lamps, L.W., Simpson, P., Hinson, J.A., and James, L.P. (2006). Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G102.
89. Donahue, B.S., and Morgan, E.T. (1990). Effects of vanadate on hepatic cytochrome P-450 expression in streptozotocin-diabetic rats. Drug Metab. Dispos. 18:519.
90. Donahue, B.S., Skottner-Lundin, A., and Morgan, E.T. (1991). Growth hormone-dependent and -independent regulation of cytochrome P-450 isozyme expression in streptozotocin-diabetic rats. Endocrinology 128:2065.
91. Dong, Z.G., Hong, J.Y., Ma, Q.A., Li, D.C., Bullock, J., Gonzalez, F.J., Park, S.S., Gelboin, H.V., and Yang, C.S. (1988). Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch. Biochem. Biophys. 263:29.
92. Donthamsetty, S., Bhave, V.S., Mitra, S.M., Latendresse, J.R., and Mehendale, H.M. (2007). Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology, in 45:391.
93. Dranoff, J.A., Masyuk, A.I., Kruglov, E.A., LaRusso, N.F., and Nathanson, M.H. (2001). Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G1059.
94. Driggers, W.J., LeDoux, S.P., and Wilson, G.L. (1993). Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. J Biol Chem. 268:22042.
95. Du, X.L., Edelstein, D., Dimmeler, S., Ju, Q., Sui, C., and Brownlee, M. (2001). Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108:1341.
96. Dulin, W.E., and Wyse, B.M. (1969). Reversal of streptozotocin diabetes with nicotinamide. Proc. Soc. Exp. Biol. Med. 130:992.
97. Duzgun, S.A., Rasque, H., Kito, H., Azuma, N., Li, W., Basson, M.D., Gahtan, V., Dudrick, S.J., and Sumpio, B.E. (2000). Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions. J. Cell Biochem. 76:567.
98. Eacho, P.I., Sweeny, D., and Weiner, M. (1981). Conjugation of p-nitroanisole and p-nitrophenol in hepatocytes isolated from streptozotocin diabetic rats. J. Pharmacol. Exp. Ther. 218:34.
99. El-Hawari, A.M., and Plaa, G.L. (1983). Potentiation of thioacetamide-induced hepatotoxicity in alloxan- and streptozotocin-diabetic rats. Toxicol. Lett. 17:293.
100. El-Serag, H.B., and Everhart, J.E. (2002). Diabetes increases the risk of acute hepatic failure. Gastroenterology 122:1822.
101. El-Serag, H.B., Tran, T., and Everhart, J.E. (2004). Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460.
102. Engels, W., van Bilsen, M., Wolffenbuttel, B.H., van der Vusse, G.J., and Glatz, J.F. (1999). Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat. Mol. Cell Biochem. 192:53.
103. English, J.C., and Anders, M.W. (1985). Evidence for the metabolism of N-nitrosodimethylamine and carbon tetrachloride by a common isozyme of cytochrome P-450. Drug Metab. Dispos. 13:449.
104. Enriquez, A., Leclercq, I., Farrell, G.C., and Robertson, G. (1999). Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem. Biophys. Res. Commun. 255:300.
105. Evans, J.L., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. (2002). Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr. Rev. 23:599.
106. Faggioni, R., Jones-Carson, J., Reed, D.A., Dinarello, C.A., Feingold, K.R., Grunfeld, C., and Fantuzzi, G. (2000). Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor alpha and IL-18. Proc. Natl. Acad. Sci. USA 97:2367.
107. Fausto, N. (2000). Liver regeneration. J. Hepatol. 32:19.
108. Fausto, N., Laird, A.D., andWebber, E.M. (1995). Liver regeneration 2: Role of growth factors and cytokines in hepatic regeneration. FASEB J. 9:1527.
109. Fausto, N., Mead, J.E., Braun, L., Thompson, N.L., Panzica, M., Goyette, M., Bell, G.I., and Shank, P.R. (1986). Proto-oncogene expression and growth factors during liver regeneration. Symp. Fundam. Cancer Res. 39:69.
110. Fausto, N., and Riehle, K.J. (2005). Mechanisms of liver regeneration and their clinical implications. J. Hepatobiliary Pancreat. Surg. 12:181.
111. Fausto, N., andWebber, E.M. (1993). Control of liver growth. Crit. Rev. Eukaryot. Gene Expr. 3:117.
112. Favreau, L.V., and Schenkman, J.B. (1988a). Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozotocin-induced diabetes and during insulin treatment. Diabetes 37:577.
113. Favreau, L.V., and Schenkman, J.B. (1988b). Cytochrome P-450 alterations in the BB/Wor spontaneously diabetic rat. Biochem. Pharmacol. 37:3505.
114. Feranchak, A.P., Fitz, J.G., and Roman, R.M. (2000). Volume-sensitive purinergic signaling in human hepatocytes. J. Hepatol. 33:174.
115. Fernandez-Martinez, A., Callejas, N.A., Casado, M., Bosca, L., and Martin-Sanz, P. (2004). Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes. J. Hepatol. 40:963.
116. Ferguson, N.L., Donahue, B.S., Tenney, K.A., and Morgan, E.T. (1993). Pretranslational induction of CYP4A subfamily gene products in diabetic rats and reversal by oral vanadate treatment. Drug Metab. Dispos. 21:745.
117. Field, C.J., and Butler, S.C. (1999). The BB rats: A unique model of human type I diabetes. In Experimental models of diabetes, ed. J. H. McNeill, p. 296. Boca Raton, FL: CRC Press.
118. Fischer, L.J., and Rickert, D.E. (1975). Pancreatic islet-cell toxicity. Crit. Rev. Toxicol. 3:231.
119. Forman, L.M., Simmons, D.A., and Diamond, R.H. (2000). Hepatic failure in a patient taking rosiglitazone.Ann. Intern. Med.132:118.
120. Fontana, R.J., and Quallich, L.G. (2001). Acute liver failure. Curr. Opin. Gastroenterol. 17:291.
121. Fredenrich, A., and Grimaldi, P.A. (2005). PPAR delta: an uncompletely known nuclear receptor. Diabetes Metab. 31:23.
122. Frigeri, L.G., Wolff, G.L., and Robel, G. (1983). Impairment of glucose tolerance in yellow (Avy/A) (BALB/c x VY) F-1 hybrid mice by hyperglycemic peptide(s) from human pituitary glands. Endocrinology 113:2097.
123. Fukano, M., Amano, S., Sato, J., Yamamoto, K., Adachi, H., Okabe, H., Fujiyama, Y., and Bamba, T. (2000). Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: A case report with autopsy examination. Hum. Pathol.31:250.
124. Fukuhara, K., Suzuki, M., Unno, M., Rahman, M.M., Endo, K., and Matsuno, S. (1999). The degree of hepatic regeneration after partial hepatectomy in rats with peritonitis and the role of lipid peroxidation. Free Radic. Biol. Med. 26:881.
125. Funae, Y., Imaoka, S., and Shimojo, N. (1988). Purification and characterization of diabetes-inducible cytochrome P-450. Biochem. Int. 16:503.
126. Funk, C., Ponelle, C., Scheuermann, G., and Pantze, M. (2001). Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol. Pharmacol. 59:627.
127. Gabel, H., Bitter-Suermann, H., Henriksson, C., Save-Soderbergh, J., Lundholm, K., and Brynger, H. (1985). Streptozotocin diabetes in juvenile pigs. Evaluation of an experimental model. Horm. Metab. Res. 17:275.
128. Galun, E., and Axelrod, J.H. (2002). The role of cytokines in liver failure and regeneration: Potential newmolecular therapies. Biochim. Biophys. Acta 1592:345.
129. Galun, E., Zeira, E., Pappo, O., Peters, M., and Rose-John, S. (2000). Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J. 14:1979.
130. Gawronska-Szklarz, B., Musial, D., Drozdzik, M., and Paprota, B. (2003). Metabolism of lidocaine by liver microsomes from streptozotocin-diabetic rats. Pol. J. Pharmacol. 55:251.
131. Gaynes, B.I., and Watkins, J.B. 3rd (1989). Carbon tetrachloride and the sorbitol pathway in the diabetic mouse. Comp. Biochem. Physiol. B. 94:213.
132. Gentile, S., Turco, S., Guarino, G., Sasso, F.C., and Torella, R. (1999). Aminotransferase activity and acarbose treatment in patients with type 2 diabetes. Diabetes Care 22:1217.
133. Gherzi, R., Andraghetti, G., Ferrannini, E., and Cordera, R. (1986). Insulin receptor autophosphorylation and kinase activity in streptozotocin diabetic rats. Effect of a short fast. Biochem. Biophys. Res. Commun. 140:850.
134. Gill, A.M., Leiter, E.H., Powell, J.G., Chapman, H.D., and Yen, T.T. (1994). Dexamethasone-induced hyperglycemia in obese Avy/a (viable yellow) female mice entails preferential induction of a hepatic estrogen sulfotransferase. Diabetes 43:999.
135. Gitlin, N., Julie, N.L., Spurr, C.L., Lim, K.N., and Juarbe, H.M. (1998). Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Ann. Intern. Med. 129:36.
136. Giugliano, D., Ceriello, A., and Paolisso, G. (1996). Oxidative stress and diabetic vascular complications. Diabetes Care 19:257.
137. Goel, K.A. (1977). Submassive necrosis of liver of Channa gachua, a fresh water fish during experimental alloxan diabetes. Anat. Anz. 141:130.
138. Gokcora, N., Gundogdu, S., Aricioglu, A., Erbas, D., Durmus, O., and Turkozkan, N. (1992). The effect of epidermal growth factor on liver lipid peroxidation and glutathione levels in lobectomized rats. Biochem. Cell Biol. 70:259.
139. Gonzalez, J., and Fevery, J. (1992). Spontaneously diabetic biobreeding rats and impairment of bile acid-independent bile flow and increased biliary bilirubin, calcium and lipid secretion. Hepatology 16:426.
140. Gopaul, N.K., Anggard, E.E., Mallet, A.I., Betteridge, D.J.,Wolff, S.P., and Nourooz-Zadeh, J. (1995). Plasma 8-epi-PGF2 alpha levels are elevated in individuals with noninsulin dependent diabetes mellitus. FEBS Lett. 368:225.
141. Graber, R., Farine, J.C., Fumagalli, I., Tatti, V., and Losa, G.A. (1999). Apoptosis and oxidative status in peripheral blood mononuclear cells of diabetic patients. Apoptosis 4:263.
142. Grant, M.H., and Duthie, S.J. (1987). Conjugation reactions in hepatocytes isolated from streptozotocin-induced diabetic rats. Biochem. Pharmacol. 36:3647.
143. Grant, M.H., and Duthie, S.J. (1988). The cytotoxicity of menadione in hepatocytes isolated from streptozotocin-induced diabetic rats. Biochem. Pharmacol. 37:3793-3796.
144. Greco, D.S. (2001). Diagnosis of diabetes mellitus in cats and dogs. Vet. Clin. North Am. Small Anim. Pract. 31:845.
145. Grussner, R., Nakhleh, R., Grussner, A., Tomadze, G., Diem, P., and Sutherland, D. (1993). Streptozotocin-induced diabetes mellitus in pigs. Horm. Metab. Res. 25:199.
146. Guebre-Xabier, M., Yang, S., Lin, H.Z., Schwenk, R., Krzych, U., and Diehl, A.M. (2000) Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: Potential mechanism for sensitization to liver damage. Hepatology 31:633.
147. Guengerich, F.P., Kim, D.H., and Iwasaki, M. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:168.
148. Guerrieri, F., Muolo, L., Cocco, T., Capozza, G., Turturro, N., Cantatore, P., and Papa, S. (1995). Correlation between rat liver regeneration and mitochondrial energy metabolism. Biochim. Biophys. Acta 1272:95.
149. Gupta, R.R., Agrawal, C.G., Shukla, G.S., and Ali, B. (1997). Cytochrome P450-dependent oxidation and glutathione conjugation of xenobiotics in alloxan-induced diabetic rat. Res. Commun. Mol. Pathol. Pharmacol. 98:231.
150. Haber, B.A., Chin, S., Chuang, E., Buikhuisen,W., Naji, A., and Taub, R. (1995). High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J. Clin. Invest. 95:832.
151. Halliwell, B. (1995). Antioxidant characterization. Methodology and mechanism. Biochem. Pharmacol. 49:1341.
152. Hanafusa, T., Miyagawa, J., Nakajima, H., Tomita, K., Kuwajima, M., Matsuzawa, Y., and Tarui, S. (1994). The NOD mouse. Diabetes Res. Clin. Pract. Suppl.:S307.
153. Hanasono, G.K., Cote, M.G., and Plaa, G.L. (1975a). Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or streptozotocin- diabetic rats. J. Pharmacol. Exp. Ther. 192:592.
154. Hanasono, G.K., Witschi, H., and Plaa, G.L. (1975b), Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc. Soc. Exp. Biol. Med. 149:903.
155. Hannon-Fletcher, M.P., O'Kane, M.J., Moles, K.W., Barnett, Y.A., and Barnett, C.R. (2001). Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects. Food Chem. Toxicol. 39:125.
156. Hans, C.P., Chaudhary, D.P., and Bansal, D.D. (2003). Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes. Res. 16:13.
157. Hansen, B.C., and Bodkin, N.L. (1993). Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes 42:1809.
158. Harrison, P.M., Hughes, R.D., Forbes, A., Portmann, B., Alexander, G.J., and Williams, R. (1990). Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. J. Hepatol. 10:332.
159. Hartnett, M.E., Stratton, R.D., Browne, R.W., Rosner, B.A., Lanham, R.J., and Armstrong, D. (2000). Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 23:234.
160. Haufroid, V., Ligocka, D., Buysschaert, M., Horsmans, Y., and Lison, D. (2003). Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: Evaluation in hepatitis C and diabetes. Eur. J. Clin. Pharmacol. 59:29.
161. He, K., Woolf, T.F., Kindt, E.K., Fielder, A.E., and Talaat, R.E. (2001). Troglitazone quinone formation catalyzed by human and rat CYP3A: An atypical CYP oxidation reaction. Biochem. Pharmacol. 62:191.
162. Held, W., MacDonald, H.R., Weissman, I.L., Hess, M.W., and Mueller, C. (1990). Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 87:2239.
163. Henderson, C.J., Bammler, T., and Wolf, C.R. (1994). Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: Developmental and hormonal regulation in liver and kidney. Biochim. Biophys. Acta 1200:182.
164. Heng, Y.M., Kuo, C.S., Jones, P.S., Savory, R., Schulz, R.M., Tomlinson, S.R., Gray, T.J., and Bell, D.R. (1997). A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochem. J. 325:741.
165. Herrman, C.E., Sanders, R.A., Klaunig, J.E., Schwarz, L.R., and Watkins, J.B. 3rd. (1999). Decreased apoptosis as a mechanism for hepatomegaly in streptozotocin-induced diabetic rats. Toxicol. Sci. 50:146.
166. Higdon, H.L., 3rd, Parnell, P.G., Hill, J.E., and Spitzer, J.C. (2001). Streptozotocin-induced pancreatic islet destruction in beef cows. Vet. Pathol. 38:715.
167. Higgins, C.M., and Anderson, R.E. (1931). Experimental pathology of the liver. Arch. Pathol. 12:186.
168. Hoenig, M. (1995). Pathophysiology of canine diabetes. Vet. Clin. North Am. Small Anim. Pract. 25:553.
169. Horn, K.D., Wax, P., Schneider, S.M., Martin, T.G., Nine, J.S., Moraca, M.A., Virji, M.A., Aronica, P.A., and Rao, K.N. (1999). Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis. Am. J. Clin. Pathol. 112:351.
170. Howard, C.F. Jr (1982). Nonhuman primates as models for the study of human diabetes mellitus. Diabetes 31:37.
171. Hsiao, S.H., Liao, L.H., Cheng, P.N., and Wu, T.J. (2006). Hepatotoxicity associated with acarbose therapy. Ann. Pharmacother. 40:151.
172. Huo, T.I., Lui, W.Y., Huand, Y.H., Chau, G.Y., Wu, J.C., Lee, P.C., Chang, F.Y., and Lee, S.D. (2003). Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: A longitudinal study. Am. J. Gastroenterol. 98:2293.
173. International Diabetes Federation, Facts & Figures. 2005. http://www.idf.org/home
174. James, L.P., Lamps, L.W., McCullough, S., and Hinson, J.A. (2003). Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem. Biophys. Res. Commun. 309:857.
175. Jang, Y.Y., Song, J.H., Shin, Y.K., Han, E.S., and Lee, C.S. (2000). Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol. Res. 42:361.
176. Jeffery, E.H., Arndt, K., and Haschek, W.M. (1991). The role of cytochrome P450IIE1 in bioactivation of acetaminophen in diabetic and acetone-treated mice. Adv. Exp. Med. Biol. 283:249.
177. Jick, S.S., Stender, M., and Myers, M.W. (1999). Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care 22:2067.
178. Johnston, D.G., Johnson, G.A., Alberti, K.G., Millward-Sadler, G.H., Mitchell, J., and Wright, R. (1986). Hepatic regeneration and metabolism after partial hepatectomy in diabetic rats: Effects of insulin therapy. Eur. J. Clin. Invest. 16:384-390.
179. Juan, D., Molitch, M.E., Johnson, M.K., Carlson, R.F., and Antal, E.J. (1990). Unaltered drug metabolizing enzyme systems in type II diabetes mellitus before and during glyburide therapy.J. Clin. Pharmacol. 30:943.
180. Kaibori, M., Inoue, T., Oda, M., Naka, D., Kawaguchi, T., Kitamura, N., Miyazawa, K., Kwon, A.H., Kamiyama, Y., and Okumura, T. (2002). Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF. Biochem. Biophys. Res. Commun. 290:475.
181. Kasiske, B.L., O'Donnell, M.P., and Keane, W.F. (1992). The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 19:I110.
182. Kassahun, K., Pearson, P.G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., and Baillie, T.A. (2001). Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission. Chem. Res. Toxicol. 14:62.
183. Kawai, K., Kawasaki-Tokui, Y., Odaka, T., Tsuruta, F., Kazui, M., Iwabuchi, H., Nakamura, T., Kinoshita, T., Ikeda, T., Yoshioka, T., Komai, T., and Nakamura, K. (1997). Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs. Arzneimittelforschung 47:356.
184. Kawakami, S., Arima, T., Harada, K., Miyazono, H., Oketani, M., Miyazaki, H., and Arima, T. (2001). Hepatic necrosis with cholestasis induced by long-term voglibose administration. Intern. Med. 40:484.
185. Kay, M.A., and Fausto, N. (1997). Liver regeneration: Prospects for therapy based on new technologies. Mol. Med. Today 3:108.
186. Kelder, B., Boyce, K., Matheny, G., Kriete, A., Cruz, S.D., Braughler, M., and Kopchick, J.J. (2004). Rapid and dramatic inhibition of Cyp3a11 and Cyp26 gene expression in a mouse model of obesity-induced type 2 diabetes. Endocr. Society 169 (Abstr.).
187. Kelley, D.E., He, J., Menshikova, E.V., and Ritov, V.B. (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944.
188. Kesavulu, M.M., Giri, R., Kameswara Rao, B., and Apparao, C. (2000). Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 26:387.
189. Kim, S.K., Abdelmegeed, M.A., and Novak, R.F. (2006). Identification of the insulin signaling cascade in the regulation of alpha-class glutathione S-transferase expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 316:1255.
190. Kim, S.K., Woodcroft, K.J., and Novak, R.F. (2003). Insulin and glucagon regulation of glutathione S-transferase expression in primary cultured rat hepatocytes. J. Pharmacol. Exp. Ther. 305:353.
191. Kinalski, M., Sledziewski, A., Telejko, B., Zarzycki, W., and Kinalska, I. (2000). Lipid peroxidation and scavenging enzyme activity in streptozotocin-induced diabetes. Acta Diabetol. 37:179.
192. King, P.A., Horton, E.D., Hirshman, M.F., and Horton, E.S. (1992). Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J. Clin. Invest. 90:1568.
193. Kirillova, I., Chaisson, M., and Fausto, N. (1999). Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ. 10:819.
194. Kirkpatrick, R.B., and Kraft, B.G. (1984). Effect of streptozotocin- induced diabetes on bile acid sulfation in male rat liver. Am. J. Physiol. 247:226.
195. Klebig, M.L., Wilkinson, J.E., Geisler, J.G., and Woychik, R.P. (1995). Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc. Natl. Acad. Sci. USA 23:4728.
196. Kohlroser, J., Mathai, J., Reichheld, J., Banner, B.F., and Bonkovsky, H.L. (2000). Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration. Am. J. Gastroenterol. 95:272.
197. Kolb, H. (1987). Mouse models of insulin dependent diabetes: Low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab. Rev. 3:751.
198. Kostrubsky, V.E., Sinclair, J.F., Ramachandran, V., Venkataramanan, R.,Wen, Y.H., Kindt, E., Galchev, V., Rose, K., Sinz, M., and Strom, S.C. (2000). The role of conjugation in hepatotoxicity of troglitazone in human and porcine hepatocyte cultures. Drug Metab. Dispos. 28:1192.
199. Kraegen, E.W., James, D.E., Storlien, L.H., Burleigh, K.M., and Chisholm, D.J. (1986). In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: Assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 29:192.
200. Kroetz, D.L., Yook, P., Costet, P., Bianchi, P., and Pineau, T. (1998). Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 273:31581.
201. Kulkarni, S.G., Warbeitton, A., Bucci, T.J., and Mehendale, H.M. (1997). Antimitotic intervention with colchicines alters the outcome of o-DCB-induced hepatotoxicity in Fischer 344 rats. Toxicology 120:79.
202. Kumashiro, R., Kubota, T., Koga, Y., Tanaka, M., Inada, C., Kusaba, N., Yoshida, H., Hisamochi, A., Ide, T., Tomita, Y., Masumoto, N., Tanikawa, K., Iga, T., and Sata, M. (2003). Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene. Hepatol. Res. 26:337.
203. Kushner, B., Lazar, M., Furman, M., Lieberman, T.W., and Leopold, I.H.(1969). Resistance of rabbits and guinea pigs to the diabetogenic effect of streptozotocin. Diabetes 18:542.
204. Kutoh, E. (2005). Possible metformin-induced hepatotoxicity. Am. J. Geriatr. Pharmacother. 3:270.
205. Kutty, K.M., Huang, S.N., and Kean, K.T. (1981). Pseudocholinesterase in obesity: Hypercaloric diet induced changes in experimental obese mice. Experientia 37:1141.
206. Kutty, K.M., and Payne, R.H. (1994). Serum pseudocholinesterase and very-low-density lipoprotein metabolism. J. Clin. Lab. Anal. 8:247.
207. Laaksonen, D.E., Atalay, M., Niskanen, L., Uusitupa, M., Hanninen, O., and Sen, C.K. (1996). Increased resting and exercise-induced oxidative stress in young IDDM men. Diabetes Care 19:569.
208. Ladosky, E.M., and Fonteles, M.C. (1988). Presynaptic changes promoted by alloxan diabetes in the cat isolated heart. J. Pharm. Pharmacol. 40:362.
209. Lakshman, M.R., Chambers, L.L., Chirtel, S.J., and Ekarohita, N. (1988). Roles of hormonal and nutritional factors in the regulation of rat liver alcohol dehydrogenase activity and ethanol elimination rate in vivo. Alcohol Clin. Exp. Res. 12:407.
210. Larsen, M.O., Wilken, M., Gotfredsen, C.F., Carr, R.D., Svendsen, O., and Rolin, B. (2002). Mild streptozotocin diabetes in the Gottingen minipig. A novel model of moderate insulin deficiency and diabetes. Am. J. Physiol. Endocrinol. Metab. 282:E1342.
211. Latha, M., and Pari, L. (2004). Effect of an aqueous extract of Scoparia dulcis on blood glucose, plasma insulin and some polyol pathway enzymes in experimental rat diabetes. Braz. J. Med. Biol. Res. 37:577.
212. Lavoie, L.N., L'Allemain, G., Brunet, A., Muller, R., and Pouyssegur, J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608.
213. Lazar, M., Golden, P., Furman, M., and Lieberman, T.W. (1968). Resistance of the rabbit to streptozotocin. Lancet 2:919.
214. Leclercq, I.A., Field, J., Enriquez, A., Farrell, G.C., and Robertson, G.R. (2000). Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. Biochem. Biophys. Res. Commun. 268:337.
215. Leclercq, I.A., Field, J., and Farrell, G.C. (2003). Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury. Gastroenterology 124:1451.
216. LeDoux, S.P., Hall, C.R., Forbes, P.M., Patton, N.J., and Wilson, G.L. (1988). Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity. Diabetes 37:1015.
217. Lee, H.C., Curry, D.L., and Stern, J.S. (1989). Direct effect of CNS on insulin hypersecretion in obese Zucker rats: Involvement of vagus nerve. Am. J. Physiol. 256:E439.
218. Leffert, H.L., Koch, K.S., Lad, P.J., Shapiro, I.P., Skelly, H., and de Hemptinnet, B. (1988). Hepatocyte regeneration, replication, and differentiation. In The Liver biology and pathbiology, eds. I.M. Arias, W.B. Jackoby, H. Popper, D. Schachter, and D.A. Shafritz, p. 883-850. New York: Raven Press.
219. Leinonen, J., Lehtimaki, T., Toyokuni, S., Okada, K., Tanaka, T., Hiai, H., Ochi, H., Laippala, P., Rantalaiho, V., Wirta, O., Pasternack, A., and Alho, H. (1997). New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 417:150.
220. Liatsos, C., Hadjileontiadis, L.J., Theocharis, S., Petridou, E., Margeli, A., Skaltsas, S., Mavrogiannis, C., and Mykoniatis, M. (2005). Using higher-order crossings to distinguish liver regeneration indices in hepatectomized diabetic and non-diabetic rats. J. Gastroenterol. Hepatol. 20:126.
221. Like, A.A., Appel, M.C., Williams, R.M., and Rossini, A.A. (1978). Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Lab. Invest. 38:470.
222. Like, A.A., and Rossini, A.A. (1976). Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415.
223. Like, A.A., Rossini, A.A., Guberski, D.L., Appel, M.C., and Williams, R.M. (1979). Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science 206:1421.
224. Lillioja, S., Mott, D.M., Spraul, M., Ferraro, R., Foley, J.E., Ravussin, E., Knowler, W.C., Bennett, P.H., and Bogardus, C. (1993) Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. 329:1988.
225. Limaye, P.B., Apte, U.M., Shankar, K., Bucci, T.J.,Warbritton, A., and Mehendale, H.M. (2003). Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants. Toxicol. Appl. Pharmacol. 191:211.
226. Limaye, P.B., Apte, U.M., Yu, S., Bhave, V.S., Palkar, P.S., Sawant, S.P., Latendresse, J.L., Reddy, J.K., and Mehendale, H.M. (2006). Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity. Hepatology 44:379.
227. Lips, J.P., Jongsma, H.W., and Eskes, T.K. (1988). Alloxan-induced diabetes mellitus in pregnant sheep and chronic fetal catheterization. Lab. Anim. 22:16.
228. Liu, S., Wang, W., Luo, X.M., and Ye, B. (2000). Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs. Hunan Yi Ke Da Xue Xue Bao 25:125.
229. Litwak, K.N., Cefalu, W.T., and Wagner, J.D. (1998). Streptozotocin- induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab. Anim. Sci. 48:172.
230. Lorr, N.A., Miller, K.W., Chung, H.R., and Yang, C.S. (1984). Potentiation of the hepatotoxicity of N-nitrosodimethylamine by fasting, diabetes, acetone, and isopropanol. Toxicol. Appl. Pharmacol. 73:423.
231. Lucas, D., Farez, C., Bardou, L.G., Vaisse, J., Attali, J.R., and Valensi, P. (1998). Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam. Clin. Pharmacol. 12:553.
232. Lukic, M.L., Stosic-Grujicic, S., and Shahin, A. (1998). Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 6:119.
233. Luo, J., Quan, J., Tsai, J., Hobensack, C.K., Sullivan, C., Hector, R., and Reaven, G.M. (1998). Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 47:663.
234. Ma, Q., Dannan, G.A., Guengerich, F.P., and Yang, C.S. (1989). Similarities and differences in the regulation of hepatic cytochrome P-450 enzymes by diabetes and fasting in male rats. Biochem. Pharmacol. 38:3179.
235. Machowicz-Matejko, E., Lancut, M., Jedrych, B., Zakrzewski, P., and Czerny, K. (2002). Ultrastructural changes of ciliary epithelial nucleus in experimental diabetes - An animal model. Ann. Univ. Mariae. Curie. Sklodowska. 57:61.
236. Madsen, L., Petersen, R.K., and Kristiansen, K. (2005). Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. Biochim. Biophys. Acta 1740: 266.
237. Mak, D.H., andKo, K.M. (1997). Alterations in susceptibility to carbon tetrachloride toxicity and hepatic antioxidant/detoxification system in streptozotocin-induced short-term diabetic rats: Effects of insulin and Schisandrin B treatment. Mol. Cell Biochem. 175:225.
238. Malatjalian, D.A., Ross, J.B., Williams, C.N., Colwell, S.J., and Eastwood, B.J. (1996). Methotrexate hepatotoxicity in psoriatics: Report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up. Can. J. Gastroenterol. 10:369.
239. Malik, A.H., Prasad, P., Saboorian, M.H., Thiele, D.L., and Malet, P.F. (2000). Hepatic injury due to troglitazone. Dig. Dis. Sci. 45:210.
240. Manautou, J.E., Emeigh Hart, S.G., Khairallah, E.A., and Cohen, S.D. (1996). Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: Effects on selective protein arylation and glutathione depletion. Fundam. Appl. Toxicol. 29:229.
241. Manautou, J.E., Hoivik, D.J., Tveit, A., Hart, S.G., Khairallah, E.A., and Cohen, S.D. (1994). Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity. Toxicol. Appl. Pharmacol. 129:252.
242. Manautou, J.E., Silva, V.M., Hennig, G.E., and Whiteley, H.E. (1998). Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice. Toxicology 127:1.
243. Mangipudy, R.S., Rao, P.S., and Mehendale, H.M. (1996). Effect of an antimitotic agent colchicine on thioacetamide hepatotoxicity. Environ. Health Perspect 104:744.
244. Mansford, K.R., and Opie, L. (1968). Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet 30:670.
245. Marchesini, G., Marzocchi, R., Noia, M., and Bianchi, G. (2005). Branched-chain amino acid supplementation in patients with liver diseases. J. Nutr. 135:1596S.
246. Maritim, A.C., Sanders, R.A., and Watkins, J.B. 3rd (2003). Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17:24.
247. Maritim, A.C., Moore, B.H., Sanders, R.A., and Watkins, J.B. 3rd (1999). Effects of melatonin on oxidative stress in streptozotocin-induced diabetic rats. Intern. J. Toxicol. 18:161.
248. Martin, G., and Rand, J. (2000). Current understanding of feline diabetes: Part 2, treatment. J. Feline Med. Surg. 2:3.
249. Matsumoto, T., Yamaguchi, M., Kuzume, M., Matsumiya, A., and Kumada, K. (2003). Insulin gene transfer with adenovirus vector via the spleen safely and effectively improves posthepatectomized conditions in diabetic rats. J. Surg. Res. 110:228.
250. Matzke, G.R., Frye, R.F., Early, J.J., Straka, R.J., and Carson, S.W. (2000). Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity. Pharmacotherapy 20:182.
251. May, L.D., Lefkowitch, J.H., Kram, M.T., and Rubin, D.E. (2002). Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy. Ann. Intern. Med. 136:449.
252. McIntosh, C.H.S., and Pederson, R.A. (1999). Noninsulin-dependent animal models of diabetes mellitus. In Experimental models of diabetes, ed. J. H. McNeill, p. 338. Boca Raton, FL: CRC Press.
253. McRobie, D.J., Glover, D.D., and Tracy, T.S. (1998). Effects of gestational and overt diabetes on human placental cytochromes P450 and glutathione S-transferase. Drug Metab. Dispos. 26:367.
254. McRobie, D.J., Korzekwa, K.R., Glover, D.D., and Tracy, T.S. (1997). The effects of diabetes on placental aromatase activity. J. Steroid Biochem. Mol. Biol. 63:147.
255. Mehendale, H.M. (1991). Role of hepatocellular regeneration and hepatolobular healing in the final outcome of liver injury. A two stage model of hepatotoxicity. Biochem. Pharmacol. 42:1155.
256. Mehendale, H.M. (1994). Amplified interactive toxicity of chemicals at nontoxic levels: mechanistic considerations and implications to public health. Environ. Health Perspect. 10:139.
257. Mehendale, H.M. (2005). Tissue repair: An important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33:41.
258. Mehendale, H.M., and Limaye, P.B. (2005). Calpain: A death protein that mediates progression of liver injury. Trends Pharmacol. Sci. 26:232.
259. Mehendale, H.M. (2007) Role of tissue repair in liver injury. In Drug-induced liver disease, 2nd ed., ed. N. Kaplowitz and L. DeLeve. Informa Healthcare, Philadelphia, PA.
260. Mekinova, D., Chorvathova,V.,Volkovova, K., Staruchova, M., Grancicova, E., Klvanova, J., and Ondreicka, R. (1995). Effect of intake of exogenous vitamins C, E and beta-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes. Nahrung 39:257.
261. Memon, R.A., Tecott, L.H., Nonogaki, K., Beigneux, A., Moser, A.H., Grunfeld, C., and Feingold, K.R. (2000). Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: Troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021.
262. Michalopoulos, G.K., and DeFrances, M.C. (1997). Liver regeneration. Science 276:60.
263. Michalopoulos, G.K., and DeFrances, M.C. (2005). Liver regeneration. Adv. Biochem. Eng. Biotechnol. 93:101.
264. Mordes, J.P., and Rossini, A.A. (1981). Animal models of diabetes. Am. J. Med. 70:353.
265. Mukherjee, B., Anbazhagan, S., Roy, A., Ghosh, R., and Chatterjee, M. (1998). Novel implications of the potential role of selenium on antioxidant status in streptozotocin-induced diabetic mice. Biomed. Pharmacother. 52:89.
266. Mukherjee, B., Mukherjee, J.R., and Chatterjee, M. (1994). Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immuno. Cell Biol. 72:109.
267. Murphy, E.J., Davern, T.J., Shakil, A.O., Shick, L., Masharani, U., Chow, H., Freise, C., Lee, W.M., and Bass, N.M. (2000). Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group. Dig. Dis. Sci. 45:549.
268. Muylle, E., van den Hende, C., Deprez, P., Nuytten, J., and Oyaert, W. (1986). Non-insulin dependent diabetes mellitus in a horse. Equine. Vet. J. 18:145.
269. Najjar, T.A., and Saad, S.Y. (2001). Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits. Chemotherapy 47:128.
270. Nakhooda, A.F., Like, A.A., Chappel, C.I., Murray, F.T., and Marliss, E.B. (1977). The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 26:100.
271. Neuschwander-Tetri, B.A., Isley, W.L., Oki, J.C., Ramrakhiani, S., Quiason, S.G., Phillips, N.J., and Brunt, E.M. (1998). Troglitazone-induced hepatic failure leading to liver transplantation. A case report. Ann. Intern. Med. 129:38.
272. Nicholls-Grzemski, F.A., Calder, I.C., and Priestly, B.G. (1992). Peroxisome proliferators protect against paracetamol hepatotoxicity in mice. Biochem. Pharmacol. 43:1395.
273. Nicholls-Grzemski, F.A., Calder, I.C., Priestly, B.G., and Burcham, P.C. (2000). Clofibrate-induced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis. Toxicol. Sci. 56:220.
274. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M.A., Beebe, D., Oates, P.J., Hammes, H.P., Giardino, I., and Brownlee, M. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404:787.
275. Nishimoto, H., Kikutani, H., Yamamura, K., and Kishimoto, T. (1987). Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328:432.
276. Nourooz-Zadeh, J., Rahimi, A., Tajaddini-Sarmadi, J., Tritschler, H., Rosen, P., Halliwell, B., and Betteridge, D.J. (1997). Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40:647.
277. Nukatsuka, M., Sakurai, H., and Kawada, J. (1989). Generation of alloxan free radicals in chemical and biological systems: Implication in the diabetogenic action of alloxan. Biochem. Biophys. Res. Commun. 165:278.
278. O'Brien, T.D. (2002). Pathogenesis of feline diabetes mellitus. Mol. Cell Endocrinol. 197:213.
279. Okamoto, H., and Yamamoto, H. (1983). DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets - A new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors. Princess Takamatsu Symp. 13:297.
280. Oliver, J.R., Jiang, S., and Cherian, M.G. (2006). Augmented hepatic injury followed by impaired regeneration in metallothionein-I/II knockout mice after treatment with thioacetamide. Toxicol. Appl. Pharmacol. 210:190.
281. Oreskovic, K., and Kunec-Vajic, E. (1992). Pseudocholinesterase in alloxan-diabetic rats. Res. Commun. Chem. Pathol. Pharmacol. 78:117.
282. Ortiz-Caro, J., Gonzalez, C., and Jolin, T. (1984). Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats. Endocrinology 15:2227.
283. Otsyula, M., King, M.S., Ketcham, T.G., Sanders, R.A., and Watkins, J.B. 3rd (2003). Oxidative stress in rats after 60 days of hypergalactosemia or hyperglycemia. Int. J. Toxicol. 22:423.
284. Ozawa, K., Yamada, T., Ukikusa, M., Ngala, K., Ida, T., Nakase, A., and Tobe, T. (1981). Mitochondrial phosphorylative activity and DNA synthesis in regenerating liver of diabetic rats. J. Surg. Res. 31:38.
285. Ozden, T.A., Uzun, H., Bohloli, M., Toklu, A.S., Paksoy, M., Simsek, G., Durak, H., Issever, H., and Ipek, T. (2004). The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats. Tohoku J. Exp. Med. 203:253.
286. Ozdogan, M., Ersoy, E., Dundar, K., Albayrak, L., Devay, S., and Gundogdu, H. (2005). Beneficial effect of hyperbaric oxygenation on liver regeneration in cirrhosis. J. Surg. Res. 129:260.
287. Pachecka, J., Kobylinska, K., Suchocka, Z., and Kuczynska, J. (1993). The effect of short-term alloxan-induced diabetes on the activity of drug metabolizing enzymes. Acta Pol. Pharm. 50:435.
288. Panepinto, L.M., Phillips, R.W., Westmoreland, N.W., and Cleek, J.L. (1982). Influence of genetics and diet on the development of diabetes in Yucatan miniature swine. J. Nutr. 112:2307.
289. Park, J.M., Moon, C.H., and Lee, M.G. (1996) Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats. Res. Commun. Mol. Pathol. Pharmacol. 93:353.
290. Pascal, M.M., Forrester, J.V., and Knott, R.M. (1999). Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells. Curr. Eye Res. 19:162.
291. Patel, B.N., Mackness, M.I., Harty, D.W., Arrol, S., Boot-Handford, R.P., and Durrington, P.N. (1990). Serum esterase activities and hyperlipidaemia in the streptozotocin-diabetic rat. Biochim. Biophys. Acta 1035:113.
292. Peavy, D.E., Taylor, J.M., and Jefferson, L.S. (1978). Correlation of albumin production rates and albumin mRNA levels in livers of normal, diabetic, and insulin-treated diabetic rats. Proc. Natl. Acad. Sci. USA 75:5879.
293. 2+-ATPase activity in heart and liver of streptozotocin-diabetic rats: Comparison with vitamin E. Biochim. Biophys. Acta 1588:71.
294. Peters, T.S. (2005).Do preclinical testing strategies help predict human hepatotoxic potentials? Toxicologic Pathology 33:146.
295. Petlevski, R., Hadzija, M., Slijepcevic, M., Juretic, D., and Petrik, J. (2003). Glutathione S-transferases and malondialdehyde in the liver of NOD mice on short-term treatment with plant mixture extract P-9801091. Phytother. Res. 17:311.
296. Pitkin, R.M., and Reynolds, W.A. (1970). Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 19:85.
297. Price, V.F., and Jollow, D.J. (1982). Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 220:504.
298. Price, V.F., and Jollow, D.J. (1984). Role of UDPGA flux in acetaminophen clearance and hepatotoxicity. Xenobiotica 14:553.
299. Price, V.F., and Jollow, D.J. (1986). Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. Biochem. Pharmacol. 35:687.
300. Pucci, L., Chirulli, V., Marini, S., Lucchesi, D., Penno, G., Gervasi, P.G., Prato, S.D., and Longo, V. (2005). Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals. Pharmacol. Res. 51:561.
301. Qin, L.Q., Wang, P.Y., Wang, Y., Kaneko, T., Hoshi, K., and Sato, A. (2005). Voglibose potentiates the hepatotoxicity of carbon tetrachloride and acetaminophen by inducing CYP2E1 in rats. Hepatol. Res. 33:50.
302. Ramachandran, V., Kostrubsky, V.E., Komoroski, B.J., Zhang, S., Dorko, K., Esplen, J.E., Strom, S.C., and Venkataramanan, R. (1999). Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes. Drug Metab. Dispos. 27:1194.
303. Ramaiah, S.K., Soni, M.G., Bucci, T.J., and Mehendale, H.M. (1998). Diet restriction enhances compensatory liver tissue repair and survival following administration of lethal dose of thioacetamide. Toxicol. Appl. Pharmacol. 150:12.
304. Rand, J. (1999). Current understanding of feline diabetes: Part 1, pathogenesis. J. Feline Med. Surg. 1:143.
305. Rao, P.S., Lyn-Cook, B.D., Littlefield, N.A., and Mehendale, H.M. (1999). High glucose concentration alters cell proliferation dynamics in human hepatoma cell. Int. J. Toxicol. 18:297.
306. 4 treated rats. Biochem. Pharmacol. 42:2323.
307. Rao, K.N., Virji, M.A., Moraca, M.A., Diven, W.F., Martin, T.G., and Schneider, S.M. (1993). Role of serum markers for liver function and liver regeneration in the management of chloroform poisoning. J. Anal. Toxicol. 17:99.
308. Rauscher, F.M., Sanders, R.A., and Watkins, J.B. 3rd (2000). Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin- induced diabetic rats. J. Biochem. Mol. Toxicol. 14:329.
309. Rauscher, F.M., Sanders, R.A., and Watkins, J.B. 3rd (2001). Effects of isoeugenol on oxidative stress pathways in normal and streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 15:159.
310. Raza, H., Ahmed, I., John, A., and Sharma, A.K. (2000). Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica charantia fruit extract. J. Biochem. Mol. Toxicol. 14:131.
311. Raza, H., Ahmed, I., Lakhani, M.S., Sharma, A.K., Pallot, D., and Montague,W. (1996). Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats. Biochem. Pharmacol. 52:1639.
312. Raza, H., Prabu, S.K., Robin, M.A., and Avadhani, N.G. (2004). Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 53:185.
313. Reed, M.J., Meszaros, K., Entes, L.J., Claypool, M.D., Pinkett, J.G., Gadbois, T.M., and Reaven, G.M. (2000). A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat. Metabolism 49:1390.
314. Richter, C. (1988). Do mitochondrial DNA fragments promote cancer and aging? FEBS Lett. 241:1.
315. Richter, C. (1992). Reactive oxygen and DNA damage in mitochondria. Mutat. Res. 275:249.
316. Richter, C., Park, J.W., and Ames, B.N. (1988). Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA 85:6465.
317. Rifik, H., and Porte, D. (1990). Ellenberg and Rifkin's diabetes mellitus: Theory and practice, 4th ed. Columbus, OH: Appleton and Lange.
318. Rolandsson, O., Haney, M.F., Hagg, E., Biber, B., and Lernmark, A. (2002). Streptozotocin induced diabetes in minipig: A case report of a possible model for type 1 diabetes? Autoimmunity 35:261.
319. Roman, R.M., and Fitz, J.G. (1999). Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function. Gastroenterology 116:964.
320. Ronco, M.T., Alvarez, M.L., Monti, J., Carrillo, M.C., Pisani, G., Lugano, M.C., and Carnovale, C.E. (2002). Modulation of balance between apoptosis and proliferation by lipid peroxidation during rat liver regeneration. Mol. Med. 8:808.
321. Rosen, P., Nawroth, P.P., King, G., Moller, W., Tritschler, H.J., and Packer, L. (2001). The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of the congress series sponsored by UNESCO-MCBN, the American diabetes association and the German diabetes society. Diabetes Metab. Res. Rev. 17:189.
322. Roth, S.I., Conaway, H.H., Sanders, L.L., Casali, R.E., and Boyd, A.E. 3rd (1980). Spontaneous diabetes mellitus in the New Zealand white rabbit: Preliminary morphologic characterization. Lab. Invest. 42:571.
323. Rouer, E., Mahu, J.L., Dansette, P., and Leroux, J.P. (1981). UDP-glucuronosyltransferase, epoxide hydrolase and glutathione S-transferase activities in the liver of diabetic mice. Biochim. Biophys. Acta 676:274.
324. Rouer, E., Mahu, J.L., Columelli, S., Dansette, P., and Leroux, J.P. (1982). Induction of drug metabolizing enzymes in the liver of diabetic mice. Biochimie 64:961.
325. Rouer, E., and Leroux, J.P. (1980). Liver microsomal cytochrome P-450 and related monooxygenase activities in genetically hyperglycemic (ob/ob and db/db) and lean streptozotocin-treated mice. Biochem. Pharmacol. 29:1959.
326. Rouer, E., Rouet, P., Delpech, M., and Leroux, J.P. (1988). Purification and comparison of liver microsomal flavin-containing monooxygenase from normal and streptozotocin-diabetic rats. Biochem. Pharmacol. 18:3455.
327. Rozga, J. (2002). Hepatocyte proliferation in health and in liver failure. Med. Sci. Monit. 8:RA32.
328. Ruiz, C., Alegria, A., Barbera, R., Farre, R., and Lagarda, M.J. (1999). Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 59:99.
329. Ruoff,W.W., Baker, D.C., Morgan, S.J., and Abbitt, B. (1986). Type II diabetes mellitus in a horse. Equine Vet. J. 18:143.
330. Runge-Morris, M., and Vento, C. (1995). Effects of streptozotocin-induced diabetes on rat liver sulfotransferase gene expression. Drug Metab. Dispos. 23:455.
331. Sahi, J., Hamilton, G., Sinz, M., Barros, S., Huang, S.M., Lesko, L.J., and LeCluyse, E.L. (2000). Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. Xenobiotica 30:273.
332. Sailaja, Y.R., Baskar, R., and Saralakumari, D. (2003). The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radical Biol. Med. 35:133.
333. Sakuma, T., Honma, R., Maguchi, S., Tamaki, H., and Nemoto, N. (2001). Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica 31:223.
334. Santini, S.A., Marra, G., Giardina, B., Cotroneo, P., Mordente, A., Martorana, G.E., Manto, A., and Ghirlanda G. (1997). Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46:1853.
335. Sawant, S.P., Dnyanmote, A.V., Shankar, K., Limaye, P.B., Latendresse, J.R., and Mehendale, H.M. (2004). Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats.J. Pharmacol. Exp. Ther. 308:694.
336. Sawant, S.P., Dnyanmote, A.V., Mitra, M.S., Chilakapati, J., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. (2006a). Protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss Webster mice. J. Pharmacol. Exp. Ther. 316:507.
337. Sawant, S.P., Dnyanmote, A.V., Warbritton, A., Latendresse, J.R., and Mehendale, H.M. (2006b). Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity. Toxicol. Appl. Pharmacol. 211:221.
338. Sawant, S.P., Dnyanmote, A.V., and Mehendale, H.M. (2007). Mechanism of inhibited liver tissue repair in toxicant challenged type 2 diabetic rats. Toxicology, 232:200.
339. Scheen, A.J. (2001). Hepatotoxicity with thiazolidinediones: Is it a class effect? Drug Safety 24:873.
340. Schmidt, L.K., and Dallhoff, K. (2005). Alpha-fetoprotein as a predictor of outcome in acetaminoiphen-induced liver injury. Hepatology 41:26-31.
341. Schnedl, W.J., Ferber, S., Johnson, J.H., and Newgard, C.B. (1994). Streptozotocin transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43:1326.
342. Schrauwen, P., and Hesselink, M.K. (2004). Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53:1412.
343. Schwabe, R.F., Bradham, C.A., Uehara, T., Hatano, E., Bennett, B.L., Schoonhoven, R., and Brenner, D.A. (2003). c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 37:824.
344. Shankar, K., Vaidya, V.S.,Wang, T., Bucci, T.J., and Mehendale, H.M. (2003a). Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity. Toxicol. Appl. Pharmacol. 188:122.
345. Shankar, K., Vaidya, V.S., Apte, U.M., Manautou, J.E., Bucci, T.J., Ronis, M.J., and Mehendale, H.M. (2003b). Type I diabetic mice are protected from acetaminophen hepatotoxicity. Toxicol. Sci. 73:220.
346. Shankar, K., Vaidya, V.S., Corton, J.C., Bucci, T.J., Liu, J., Waalkes, M.P., and Mehendale, H.M. (2003c). Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity. FASEB J. 17:1748.
347. Sharma, A.D., Cantz, T., Richter, R., Eckert, K., Henschler, R., Wilkens, L., Jochheim-Richter, A., Arseniev, L., and Ott, M. (2005). Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am. J. Pathol. 167:555.
348. Shayiq, R.M., Roberts, D.W., Rothstein, K., Snawder, J.E., Benson, W., Ma, X., and Black, M. (1999). Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology 29:451.
349. Sheweita, S.A., Newairy, A.A., Mansour, H.A., and Yousef, M.I. (2002). Effect of some hypoglycemic herbs on the activity of phase I and II drug-metabolizing enzymes in alloxan-induced diabetic rats. Toxicology 174:131.
350. Shibuya, A., Watanabe, M., Fujita, Y., Saigenji, K., Kuwao, S., Takahashi, H., and Takeuchi, H. (1998). An autopsy case of troglitazone-induced fulminant hepatitis. Diabetes Care 21:2140.
351. Shimojo, N. (1994). Cytochrome P450 changes in rats with streptozocin-induced diabetes. Int. J. Biochem. 26:1261.
352. Shimojo, N., Ishizaki, T., Imaoka, S., Funae, Y., Fujii, S., and Okuda, K. (1993). Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozotocin-induced diabetes. Biochem. Pharmacol. 46:621.
353. Sidhu, J.S., Liu, F., Boyle, S.M., and Omiecinski, C.J. (2001). PI3K inhibitors reverse the suppressive actions of insulin on CYP2E1 expression by activating stress-response pathways in primary rat hepatocytes. Mol. Pharmacol. 59:1138.
354. Siegmund, B., Lear-Kaul, K.C., Faggioni, R., and Fantuzzi, G. (2002). Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur. J. Immunol. 32:552.
355. Sima, A., and Shafrir, E. (2001). Animal models of diabetes: A primer. Amsterdam: Overseas Publishers Association.
356. Simek, J., Chmelar, V., Melka, J., Pazderka, J., and Charvat, Z. (1967). Influence of protracted infusion of glucose and insulin on the composition and regeneration activity of liver after partial hepatectomy in rats. Nature 213:910.
357. Simon, J., and Dubois, M.P. (1980). Failure of a sublethal streptozotocin dose to induce diabetes in the chicken. Horm. Metab. Res. 12:631.
358. Sitbon, G., Laurent, F., Mialhe, A., Krug, E., Karmann, H., Gross, R., Strosser, M.T., Cohen, L., Jean-Marie, P., Foltzer, C., and Mialhe, P. (1980). Diabetes in birds. Horm. Metab. Res. 12:1.
359. Skrha, J., Hodinar, A., Kvasnicka, J., and Hilgertova, J. (1996). Relationship of oxidative stress and fibrinolysis in diabetes mellitus. Diabet. Med. 13:800.
360. Song, B.J., Veech, R.L., and Saenger, P. (1990). Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J. Clin. Endocrinol. Metab. 71:1036.
361. Soni, M.G., Ramaiah, S.K., Mumtaz, M.M., Clewell, H., and Mehendale, H.M. (1999). Toxicant-inflicted injury and stimulated tissue repair are opposing toxicodynamic forces in predictive toxicology. Regul. Toxicol. Pharmacol. 29:165.
362. Sotaniemi, E.A., Pelkonen, O., Arranto, A.J., Tapanainen, P., Rautio, A., and Pasanen, M. (2002). Diabetes and elimination of antipyrine in man: An analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement. Pharmacol. Toxicol. 90:155.
363. Starzl,T.E., Francavilla, A., Halgrimson, C.G., Francavilla, F.R., Porter, K.A., Brown, T.H., and Putnam, C.W. (1973). The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg. Gynecol. Obstet. 137:179.
364. Steiner, D.F., and King, J. (1966). Insulin-stimulated ribonucleic acid synthesis and RNA polymerase activity in alloxan-diabetic rat liver. Biochim. Biophys. Acta 119:510.
365. Stogdale, L. (1986). Definition of diabetes mellitus. Cornell Vet. 76:156.
366. Stralfors, P. (1997). Insulin second messengers. Bioessays 19:327.
367. Stumvoll, M., and Haring, H.U. (2002). Glitazones: clinical effects and molecular mechanisms. Ann. Med. 34:217.
368. Suchocka, Z., Kobylinska, K., and Pachecka, J. (1995). Activity of glutathione-dependent enzymes in long term diabetes. I. Activity of glutathione S-transferase and glutathione peroxidase in the liver of alloxan induced diabetic rats. Acta Pol. Pharm. 52:207.
369. Swamy-Mruthinti, S., Shaw, S.M., Zhao, H.R., Green, K., and Abraham, E.C. (1999). Evidence of a glycemic threshold for the development of cataracts in diabetic rats. Curr. Eye Res. 18:423.
370. Takada, H., Uchida, A., Kamizono, R., Otagiri, M., and Imamura, Y. (2000). Further studies on 20beta-hydroxysteroid dehydrogenase with carbonyl reductase-like activity present in liver microsomes of male rats. Life Sci. 67:2075.
371. 2 as mediator for DNA fragmentation. Diabetes 40:1141.
372. Tang, P.M., Finkelstein, J.A., and Chiang, J.Y. (1988). Expression of hepatic microsomal cholesterol 7 alpha-hydroxylase activity in lean and obese Zucker rats. Biochem. Biophys. Res. Commun. 150:853.
373. Taniyama, H., Shirakawa, T., Furuoka, H., Osame, S., Kitamura, N., and Miyazawa, K. (1993). Spontaneous diabetes mellitus in young cattle: Histologic, immunohistochemical, and electron microscopic studies of the islets of Langerhans. Vet. Pathol. 30:46.
374. Taniyama, H., Hirayama, K., Kagawa, Y., Kurosawa, T., Tajima, M., Yoshino, T., and Furuoka, H. (1999). Histopathological and immunohistochemical analysis of the endocrine and exocrine pancreas in twelve cattle with insulin-dependent diabetes mellitus (IDDM). J. Vet. Med. Sci. 61:803.
375. Taub, R. (2003). Hepatoprotection via the IL-6/Stat3 pathway. J. Clin. Invest. 112:978.
376. Tannenbaum, G.S. (1981). Growth hormone secretory dynamics in streptozotocin diabetes: Evidence of a role for endogenous circulating somatostatin. Endocrinology 108:76.
377. 4 autoprotection. Toxicol. Pathol. 19:47.
378. Theriault, B.R., Thistlethwaite, J.R., Jr., Levisetti, M.G.,Wardrip, C.L., Szot, G., Bruce, D.S., Rilo, H., Li, X., Gray, G.S., Bluestone, J.A., and Padrid, P.A. (1999). Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). Transplantation 68:331.
379. Thevananther, S., Sun, H., Li, D., Arjunan, V., Awad, S.S., Wyllie, S., Zimmerman, T.L., Goss, J.A., and Karpen, S.J. (2004). Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 39:393.
380. Thomas, H., Schladt, L., Knehr, M., and Oesch, F. (1989). Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation. Biochem. Pharmacol. 38:4291.
381. Thompson, N.L., Mead, J.E., Braun, L., Goyette, M., Shank, O.R., and Fausto, N. (1986). Sequential protooncogene expression during rat liver regeneration. Cancer Res. 46:3111.
382. Thummel, K.E., and Schenkman, J.B. (1990). Effects of testosterone and growth hormone treatment on hepatic microsomal P450 expression in the diabetic rat. Mol. Pharmacol. 37:119.
383. Tofovic, S.P., and Jackson, E.K. (2003). Rat models of the metabolic syndrome. Methods Mol. Med. 86:29.
384. Toleikis, P.M., and Godin, D.V. (1995). Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors. Pharmacol. Biochem. Behav. 52:355.
385. Torbenson, M., Yang, S.Q., Liu, H.Z., Huang, J., Gage, W., and Diehl, A.M. (2002). STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am. J. Pathol.161:155.
386. Traverso, N., Menini, S., Odetti, P., Pronzato, M.A., Cottalasso, D., and Marinari, U.M. (2002). Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radical Biol. Med. 32:350.
387. Truett, G.E., Bahary, N., Friedman, J.M., and Leibel, R.L. (1991). Rat obesity gene fatty (fa) maps to chromosome 5: evidence for homology with the mouse gene diabetes (db). Proc. Natl. Acad. Sci. USA 88:7806.
388. Tsiani, E., Lekas, P., Fantus, I.G., Dlugosz, J., and Whiteside, C. (2002). High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am. J. Physiol. Endocrinol. Metab. 282:E161.
389. Tuntaterdtum, S., Chaudhary, I.P., Cibull, M., Robertson, L.W., and Blouin, R.A. (1993). Acetaminophen hepatotoxicity: influence of phenobarbital and beta-naphthoflavone treatment in obese and lean Zucker rats. Toxicol. Appl. Pharmacol. 123:219.
390. Turmelle, Y.P., Shikapwashya, O., Tu, S., Hruz, P.W., Yan, Q., and Rudnick, D.A. (2006). Rosiglitazone inhibits mouse liver regeneration. FASEB J. 20:2609.
391. Uphues, I., Kolter, T., Goud, B., and Eckel, J. (1995). Failure of insulin-regulated recruitment of the glucose transporter GLUT4 in cardiac muscle of obese Zucker rats is associated with alterations of small-molecular-mass GTP-binding proteins. Biochem. J. 311:161.
392. VanderJagt, D.J., Harrison, J.M., Ratliff, D.M., Hunsaker, L.A., and VanderJagt, D.L. (2001). Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem. 34:265.
393. Vega, P., Gaule, C., Mancilla, J., and del Villar, E. (1993). Comparison of alloxan and streptozotocin induced diabetes in rats: Differential effects on microsomal drug metabolism. Gen. Pharmacol. 24:489.
394. Vega, P., Gaule, C., Sanchez, E., and delVillar, E. (1986). Inhibition and activation of UDP-glucuronyltransferase in alloxanic-diabetic rats. Gen. Pharmacol. 17:641.
395. Virji, M.A., Venkataraman, S.T., Lower, D.R., and Rao, K.N. (2003). Role of laboratory in the management of phenylbutazone poisoning. J. Toxicol. Clin. Toxicol. 41:1013.
396. Von Mehring, J., and Minkowski, J. (1890). diabetes mellitus nach pankresexstirpation. Arch. Exp. Path. 26:371.
397. Wagner, J.D., Cline, J.M., Shadoan, M.K., Bullock, B.C., Rankin, S.E., and Cefalu, W.T. (2001). Naturally occurring and experimental diabetes in cynomolgus monkeys: A comparison of carbohydrate and lipid metabolism and islet pathology. Toxicol. Pathol. 29:142.
398. Wang, T., Fonetenot, R.D., Soni, M.G., Bucci, T.J., and Mehendale, H.M. (2000a). Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats. Toxicol. Appl. Pharmacol. 166:92.
399. Wang, T., Shankar, K., Ronis, M.J., and Mehendale, H.M. (2000b). Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J. Pharmacol. Exp. Ther. 294:473.
400. Wang, T., Shankar, K., Bucci, T.J., Warbritton, A., and Mehendale, H.M. (2001). Diallyl Sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality. Toxicol. Appl. Pharmacol. 173:27.
401. Wang, X., Hung, N.J., and Costa, R.H. (2001). Earlier expression of the transcription factor HFH-11B diminishes induction of p21(CIP1/WAF1) levels and accelerates mouse hepatocyte entry into S-phase following carbon tetrachloride liver injury. Hepatology 33:1404.
402. Wang, Z., Hall, S.D., Maya, J.F., Li, L., Asghar, A., and Gorski, J.C. (2003). Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br. J. Clin. Pharmacol. 55:77.
403. Watanabe, T., Furukawa, T., Sharyo, S., Ohashi, Y., Yasuda, M., Takaoka, M., and Manabe, S. (2000). Effect of troglitazone on the liver of a Gunn rat model of genetic enzyme polymorphism. J. Toxicol. Sci. 25:423.
404. Watkins, J.B. 3rd, and Klueber, K.M. (1988). Hepatic phase II biotransformation in C57Bl/KsJ db/db mice: comparison to that in Swiss Webster and 129 REJ mice. Comp. Biochem. Physiol. C. 90:417.
405. Watkins, J.B. 3rd, and Sanders, R.A. (1995). Diabetes mellitus-induced alteration of hepatobiliary functions. Pharmacol. Rev. 47:1.
406. Watkins, J.B. 3rd, Sanders, R.A., and Beck, L.V. (1988). The effect of long-term streptozotocin-induced diabetes on the hepatotoxicity of bromobenzene and carbon tetrachloride and hepatic biotransformation in rats. Toxicol. Appl. Pharmacol. 93:329.
407. Watkins, J.B. 3rd, and Sherman, S.E. (1992). Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. J. Pharmacol. Exp. Ther. 260:1337.
408. Watkins, P.B. (2005a). Idiosyncratic liver injury: Challenges and approaches. Toxicol. Pathol. 33:1.
409. Watkins, P.B. (2005b). Insight into hepatotoxicity: The troglitazone experience. Hepatology 41:229.
410. Watkins, P.B., and Whitcomb, R.W. (1998). Hepatic dysfunction associated with troglitazone. N. Engl. J. Med. 338:916.
411. Webber, E.M., Bruix, J., Pierce, R.H., and Fausto, N. (1998). Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 28:1226.
412. Webber, E.M., Godowski, P.J., and Fausto, N. (1994). In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 14:489.
413. Weide, L.G., and Lacy, P.E. (1991). Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model. Diabetes 40:1157.
414. West, I.C. (2000). Radicals and oxidative stress in diabetes. Diabetic Med. 17:171.
415. Wilkinson, M.G., and Millar, J.B. (2000). Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J. 14:2147.
416. Wilson, G.L., Patton, N.J., McCord, J.M., Mullins, D.W., and Mossman, B.T. (1984). Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells. Diabetologia 27:587.
417. Woodcroft, K.J., Hafner, M.S., and Novak, R.F. (2002). Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 35:263.
418. Xi, S., Yin, W., Wang, Z., Kusunoki, M., Lian, X., Koike, T., Fan, J., and Zhang, Q. (2004). A minipig model of high-fat/high-sucrose diet-induced diabetes and atherosclerosis. Int. J. Exp. Pathol. 85:223.
419. Yamada, Y., and Fausto, N. (1998). Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152:1577.
420. Yamada, Y., Kirillova, I., Peschon, J.J., and Fausto, N. (1997). Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94:1441.
421. Yamada, T., Yamamoto, M., Ozawa, K., and Honjo, I. (1977). Insulin requirements for hepatic regeneration following hepatectomy. Ann. Surg. 185:35.
422. Yamaguchi, M.,Kuzume, M., Matsumoto, T., Shimura, H., Matsumiya, A., Nakano, H., Takeda, M., Sanada, Y., and Kumada, K. (2000). Adenovirus-mediated insulin gene transfer improves nutritional and post-hepatectomized conditions in diabetic rats. Surgery 127:670.
423. Yamamoto, H., Uchigata, Y., and Okamoto, H. (1981). Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294:284.
424. Yamasaki, H., Saibara, T., Maeda, T., and Onishi, S. (1995). The arterial ketone body ratio and serum alpha-fetoprotein level in patients with acute hepatic failure. Liver 15:219.
425. Yamazaki, H., Shibata, A., Suzuki, M., Nakajima, M., Shimada, N., Guengerich, F.P., and Yokoi, T. (1999). Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metab. Dispos. 27:1260.
426. Yamazoe, Y., Mrayama, N., Shimada, M., Yamauchi, K., and Kato, R. (1989). Cytochrome P450 in livers of diabetic rats: Regulation by growth hormone and insulin. Arch. Biochem. Biophys. 268:567.
427. Yamazoe, Y., Ling, X., Murayama, N., Gong, D., Nagata, K., and Kato, R. (1990). Modulation of hepatic level of microsomal testosterone 7 alpha-hydroxylase, P-450a (P450IIA), by thyroid hormone and growth hormone in rat liver. J. Biochem. (Tokyo) 108:599.
428. Yanardag, R., Ozsoy-Sacan, O., Orak, H., and Ozgey, Y. (2005). Protective effects of glurenorm (gliquidone) treatment on the liver injury of experimental diabetes. Drug Chem. Toxicol. 28:483.
429. Yang, S.Q., Lin, H.Z., Mandal, A.K., Huang, J., and Diehl, A.M. (2001). Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34:694.
430. Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M., and Diehl, A.M. (1997). Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94:2557.
431. Yen, T.T., Gill, A.M., Frigeri, L.G., Barsh, G.S., and Wolff, G.L. (1994). Obesity, diabetes, and neoplasia in yellow Avy mice: Ectopic expression of the agouti gene. FASEB J. 8:479.
432. Yin, W., Liao, D., Kusunoki, M., Xi, S., Tsutsumi, K., Wang, Z., Lian, X., Koike, T., Fan, J., Yang, Y., and Tang, C. (2004). NO-1886 decreases ectopic lipid deposition and protects pancreatic beta cells in diet-induced diabetic swine. J. Endocrinol. 180:399.
433. Younger, L.R., King, J., and Steiner, D.F. (1966). Hepatic proliferative response to insulin in severe alloxan diabetes. Cancer Res. 26:1408.
434. Yoshigae, Y., Konno, K., Takasaki, W., and Ikeda, T. (2000). Characterization of UDP-glucuronosyltransferases (UGTS) involved in the metabolism of troglitazone in rats and humans. J. Toxicol. Sci. 25:433.
435. Yoshinari, K., Takagi, S., Sugatani, J., and MIWA, M. (2006). Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db/db mice. Biol. Pharm. Bull. 29:1634.
436. Zaluzny, L., Farrell, G. C., and Murray, M. (1990). Effect of genetic obesity and experimental diabetes on hepatic microsomal mixed function oxidase activities. J. Gastroenterol. Hepatol. 5:256.
437. Zannikos, P.N., Bandyopadhyay, A.M., Robertson, L.W., and Blouin, R.A. (1994). Cytochrome P450 2B enzyme induction defect after 2,2′,4,4′, 5,5′-hexachlorobiphenyl treatment in the fa/fa Zucker rat. J. Pharmacol. Exp. Ther. 268:1565.
438. Zemel, M.B., Kim, J.H., Woychik, R.P., Michaud, E.J., Kadwell, S.H., Patel, I.R., and Wilkison, W.O. (1995). Agouti regulation of intracellular calcium: Role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA 92:4733.
439. Ziegler, D.M. (1980). Microsomal flavin-containing monooxygenases: Oxygen of nucleophilic nitrogen and sulfur compounds. In Enzymatic basis of detoxication, ed. W.B. Jacoby, p. 201. New York: Academic Press.
440. Zimmers, T.A., McKillop, I.H., Pierce, R.H., Yoo, J.Y., and Koniaris, L.G. (2003). Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology 38:326.